Whittier Trust Co. of Nevada Inc. Boosts Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Whittier Trust Co. of Nevada Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 77,355 shares of the company’s stock after purchasing an additional 3,240 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in GE HealthCare Technologies were worth $6,047,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of GEHC. Cherry Creek Investment Advisors Inc. boosted its holdings in GE HealthCare Technologies by 0.3% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky boosted its stake in shares of GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after buying an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV grew its holdings in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after acquiring an additional 118 shares during the period. Arcus Capital Partners LLC raised its position in GE HealthCare Technologies by 3.0% in the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock worth $322,000 after acquiring an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC lifted its holdings in GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock valued at $222,000 after acquiring an additional 120 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $81.49 on Friday. The company has a market cap of $37.27 billion, a P/E ratio of 18.82, a P/E/G ratio of 3.19 and a beta of 1.13. The firm’s 50 day moving average is $87.02 and its two-hundred day moving average is $86.02. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analyst Weigh In

GEHC has been the subject of several recent analyst reports. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.